IARTIntegra LifeSciences Holdings Corporation
What is the market doing?
No clear lean: rangebound and heavily shorted.
Rangebound, no clear trend. Price is −2% vs its 200-day average.
Heavily shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How IART is trading
Integra LifeSciences Holdings Corporation is −4.9% over the past year while the S&P 500 is +18%: 23 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −2.4%
vs 200-day average · below trend, but not far
- RSI (14)
- 36
RSI (14) · neutral
- Below its 52-week high
- 32%
Below its 52-week high
Details›
- Last close2026-10-09
- $13.44
- 1 monthS&P 500 +2.7%
- −14%
- 1 yearS&P 500 +18%
- −4.9%
- 5 yearsS&P 500 +88%
- −81%
- vs 50-day average$16.34
- −18%
- 52-week high
- $19.86
- 52-week low
- $8.90
- Annualised volatility
- 62%
| Year | Return |
|---|---|
| 2026 (year to date) | +8.2% |
| 2025 | −45% |
| 2024 | −48% |
| 2023 | −22% |
| 2022 | −16% |
| 2021 | +3.2% |
| 2020 | +11% |
| 2019 | +29% |
| 2018 | −5.8% |
| 2017 | +12% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 5 of 10 | +0.43% |
| Feb | 10 | 6 of 10 | +0.07% |
| Mar | 10 | 4 of 10 | −3.6% |
| Apr | 10 | 5 of 10 | −0.41% |
| May | 10 | 6 of 10 | +0.52% |
| Jun | 10 | 4 of 10 | +1.6% |
| Jul | 11 | 8 of 11 | +2.6% |
| Aug | 11 | 5 of 11 | −3.4% |
| Sep | 11 | 2 of 11 | −4.2% |
| Oct | 11 | 2 of 11 | −5.5% |
| Nov | 10 | 9 of 10 | +9.0% |
| Dec | 10 | 5 of 10 | +0.78% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.